Profile
Kirk Taylor served as the Chief Medical Officer & Executive Vice President at Brainstorm Cell Therapeutics, Inc. in 2023 and as the Senior VP-Medical Affairs Strategy & Operations at Verastem, Inc. from 2018 to 2019.
He completed his undergraduate studies at Harvard University, his graduate studies at The University of California, San Francisco, and his doctorate at State University of New York at Downstate Medical Center.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-04-30 | 35,000 ( 0.05% ) | 18 620 $ | 2024-04-29 |
Former positions of Kirk Taylor
| Companies | Position | End |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2023-10-17 |
| VERASTEM, INC. | Corporate Officer/Principal | 2019-07-31 |
Training of Kirk Taylor
| Harvard University | Undergraduate Degree |
| State University of New York at Downstate Medical Center | Doctorate Degree |
| The University of California, San Francisco | Graduate Degree |
Experiences
Positions held
Connections
17
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| VERASTEM, INC. | Health Technology |
| BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
- Stock Market
- Insiders
- Kirk Taylor
